What have we learned: Adapting to RWE regulatory guidance and experience (56:36)

Given the recent release of various guidances from global health authorities, the regulatory use of real-world evidence (RWE) continues to evolve. At the same time, using RWE to support regulatory submissions continues to be a key focus area for both regulators and life sciences companies. In this ResearchX session, industry leaders shared their experiences with regulatory applications of RWE in various contexts and discussed how RWE can meaningfully contribute to regulatory submissions. Specific case studies were also shared.